Royalty Pharma CFO Terrance P. Coyne sells USD 645,248 in common shares
RPRX•Insider share sale disclosed
- Royalty Pharma EVP and CFO Terrance P. Coyne sold 11,002 Class A ordinary shares on Aug. 13.
- Sales averaged USD 58.59 for 9,230 shares, then USD 59.14 for 1,772 shares, via TPC RP EPA1 LLC.
- TPC RP EPA1 LLC’s stake fell to zero shares.




